CRISPR Therapeutics AG

General ticker "CRSP" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $4.0B (TTM average)

CRISPR Therapeutics AG follows the US Stock Market performance with the rate: 6.5%.

Estimated limits based on current volatility of 2.0%: low 37.16$, high 38.69$

Factors to consider:

  • Earnings expected soon, date: 2025-05-14 bmo
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [20.14$, 47.44$]
  • 2025-12-31 to 2026-12-31 estimated range: [12.74$, 31.95$]

Financial Metrics affecting the CRSP estimates:

  • Negative: Non-GAAP EPS, $ of -4.37 <= 0.04
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -3.50 <= 1.79
  • Negative: negative Net income
  • Negative: negative Industry operating income (median)

Similar symbols

Short-term CRSP quotes

2025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-0230323436384042
Price $

Long-term CRSP plot with estimates

102030405060708090Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1.5−1−0.50
CRSPS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.44MM $371.21MM $35.00MM
Operating Expenses $673.60MM $593.74MM $501.57MM
Operating Income $-673.16MM $-222.54MM $-466.57MM
Non-Operating Income $22.66MM $71.82MM $103.90MM
R&D Expense $461.64MM $387.33MM $320.65MM
Income(Loss) $-650.50MM $-150.72MM $-362.67MM
Taxes $-0.33MM $2.89MM $3.59MM
Profit(Loss)* $-650.17MM $-153.61MM $-366.25MM
Stockholders Equity $1,875.48MM $1,882.80MM $1,932.08MM
Inventory $11.20MM $0.00MM $0.00MM
Assets $2,243.06MM $2,229.57MM $2,242.03MM
Operating Cash Flow $-495.74MM $-260.38MM $-142.77MM
Capital expenditure $37.19MM $11.97MM $1.90MM
Investing Cash Flow $-258.65MM $374.65MM $-280.48MM
Financing Cash Flow $38.59MM $62.66MM $331.98MM
Earnings Per Share** $-8.36 $-1.94 $-4.34

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.